Faster Implementation, Faster ROI: MilliporeSigma's 97-Day Journey to Operational Efficiency with the ValGenesis platform
MilliporeSigma needed to modernize its manual, time-consuming validation processes. It implemented the ValGenesis platform, leveraging vendor documentation to accelerate rollout and completing full implementation in 97 days. Results: implementation completed in 97 days, 100 hours saved during testing and validation, 20-25 hours per week reduction in validation workload, and 50% of the investment recouped in just 20 weeks -- with improved data integrity, compliance and validation execution, laying a foundation for broader adoption across sites.
ValGenesis is a digital validation-lifecycle platform — one of the two dominant players, alongside Kneat, in producing the validation evidence a GxP system needs before it can go live.
This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.
Published by ValGenesis on its own site — read the original case study on valgenesis.com ↗
Related use cases
- 01Pharma Innovator Leverages Digital CPV to Boost Statistical Control and Cut Reporting Time from Two Weeks to Three Days
- 02Catalent's Journey of Continuous Improvement for CSV Excellence
- 03Noven - ValGenesis
- 04Transcat
- 05Theragent
- 06Cut CSV process steps 40%, validation cycle time down 25% via integrated processes — (URL not separately confirmed; referenced in ValGenesis blog/resource content